Matches in Wikidata for { <http://www.wikidata.org/entity/Q92851859> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q92851859 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92851859 description "im August 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92851859 description "scientific article published on 26 August 2019" @default.
- Q92851859 description "wetenschappelijk artikel" @default.
- Q92851859 description "наукова стаття, опублікована 26 серпня 2019" @default.
- Q92851859 name "Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes" @default.
- Q92851859 name "Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes" @default.
- Q92851859 type Item @default.
- Q92851859 label "Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes" @default.
- Q92851859 label "Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes" @default.
- Q92851859 prefLabel "Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes" @default.
- Q92851859 prefLabel "Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes" @default.
- Q92851859 P1433 Q92851859-AFEC9BA5-084B-45B3-9B20-778E2D40882A @default.
- Q92851859 P1476 Q92851859-0D95A842-7ACE-410B-8ADE-E0D4DBDD18ED @default.
- Q92851859 P2093 Q92851859-5AE57E29-CDA5-4622-AA0B-EA26E701F9B0 @default.
- Q92851859 P2093 Q92851859-768745D2-9797-48A7-A66E-9F04AEC20151 @default.
- Q92851859 P2093 Q92851859-7C9D2B04-AE69-4B58-B82A-4F676E9D683B @default.
- Q92851859 P2093 Q92851859-D9CFC640-2072-4861-9A9D-222242FF6A0C @default.
- Q92851859 P2093 Q92851859-DA42EACF-23AF-47CB-A326-5E438BAC9E8B @default.
- Q92851859 P2093 Q92851859-DEA4395B-380D-42BA-B241-CFE9A7D4200C @default.
- Q92851859 P304 Q92851859-8EC13A50-78C0-419F-A656-894BB65895E5 @default.
- Q92851859 P31 Q92851859-9B06B64A-3AF3-498C-A1B7-239B98EE757B @default.
- Q92851859 P356 Q92851859-5876034D-5B1B-4F00-93AE-70F714D661DA @default.
- Q92851859 P433 Q92851859-F15FFF9A-970D-4DC1-803A-DBBD1BAF9889 @default.
- Q92851859 P478 Q92851859-8DF76DCE-ABFE-4543-A852-9A9956424F23 @default.
- Q92851859 P577 Q92851859-B12C06FA-34E0-4CC4-B58C-7F84B5EB06F3 @default.
- Q92851859 P698 Q92851859-99814DB3-326C-431C-8D47-A69081C07464 @default.
- Q92851859 P921 Q92851859-F56622AD-015A-434B-A090-0FBE7AE2A5CA @default.
- Q92851859 P356 HYPERTENSIONAHA.119.13348 @default.
- Q92851859 P698 31446801 @default.
- Q92851859 P1433 Q5958695 @default.
- Q92851859 P1476 "Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes" @default.
- Q92851859 P2093 "Alfredo Leaños-Miranda" @default.
- Q92851859 P2093 "Claudia Stephanny Navarro-Romero" @default.
- Q92851859 P2093 "Irma Isordia-Salas" @default.
- Q92851859 P2093 "Karla Leticia Ramírez-Valenzuela" @default.
- Q92851859 P2093 "Liliana Janet Sillas-Pardo" @default.
- Q92851859 P2093 "Luis Manuel Jiménez-Trejo" @default.
- Q92851859 P304 "991-997" @default.
- Q92851859 P31 Q13442814 @default.
- Q92851859 P356 "10.1161/HYPERTENSIONAHA.119.13348" @default.
- Q92851859 P433 "4" @default.
- Q92851859 P478 "74" @default.
- Q92851859 P577 "2019-08-26T00:00:00Z" @default.
- Q92851859 P698 "31446801" @default.
- Q92851859 P921 Q61335 @default.